Application Sponsors
| ANDA 212602 | INVAGEN PHARMS |  | 
Marketing Status
Application Products
| 001 | TABLET;ORAL | 625MG | 0 | COLESEVELAM HYDROCHLORIDE | COLESEVELAM HYDROCHLORIDE | 
FDA Submissions
| UNKNOWN;  | ORIG | 1 | AP | 2020-04-20 | STANDARD  | 
Submissions Property Types
TE Codes
CDER Filings
INVAGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212602
            [companyName] => INVAGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"COLESEVELAM HYDROCHLORIDE","activeIngredients":"COLESEVELAM HYDROCHLORIDE","strength":"625MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/20\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-04-20
        )
)